Disclosure 0001614740-26-000013-2

SEC FORM 4

$815,240.96

Mirum Pharmaceuticals, Inc. (MIRM)

Sale of 8,312 shares at $98.08 per share.

Reporting Person Peetz Christopher · Officer Title CHIEF EXECUTIVE OFFICER · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001614740-26-000013 · filed 2026-09-03 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Mirum Pharmaceuticals, Inc. (MIRM)." Disclosed 2026-09-03. https://desqlong.com/cards/0001614740-26-000013-2 (retrieved 2026-09-26).